Preferred Label : Alport syndrome 2, autosomal recessive;
Symbol : ATS2;
CISMeF acronym : ATS2;
Type : Phenotype, molecular basis known;
Description : Alport syndrome is a hereditary disorder of the basement membrane, resulting in a
glomerulonephropathy causing renal failure. Progressive deafness and ocular anomalies
may also occur (Mochizuki et al., 1994; Colville et al. (1997)). For a general phenotypic
description of Alport syndrome, see the X-linked dominant form (301050). Approximately
85% of cases of Alport syndrome are X-linked and about 15% are autosomal recessive;
autosomal dominant inheritance (104200) is rare (van der Loop et al., 2000). See also
benign familial hematuria (BFH; 141200), a similar but milder disorder.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the collagen, type IV, alpha-4 gene (COL4A4, 120131.0001); Caused by mutation in the collagen, type IV, alpha-3 gene (COL4A3, 120070.0001);
Laboratory abnormalities : Hematuria, gross and microscopic; Proteinuria; Nephrotic syndrome;
Prefixed ID : #203780;
Origin ID : 203780;
UMLS CUI : C4746745;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT